Aptamers: potential diagnostic and therapeutic agents for blood diseases
Aptamers are RNA/DNA oligonucleotide molecules that specifically bind to a targeted
complementary molecule. As potential recognition elements with promising diagnostic and …
complementary molecule. As potential recognition elements with promising diagnostic and …
Overview of the therapeutic potential of aptamers targeting coagulation factors
M Liu, K Zaman, YM Fortenberry - International Journal of Molecular …, 2021 - mdpi.com
Aptamers are single-stranded DNA or RNA sequences that bind target molecules with high
specificity and affinity. Aptamers exhibit several notable advantages over protein-based …
specificity and affinity. Aptamers exhibit several notable advantages over protein-based …
[HTML][HTML] Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells
MM Lee‐Sundlov, SR Stowell… - Journal of Thrombosis and …, 2020 - Elsevier
Glycosylation is highly prevalent, and also one of the most complex and varied
posttranslational modifications. This large glycan diversity results in a wide range of …
posttranslational modifications. This large glycan diversity results in a wide range of …
Desialylation of O-glycans on glycoprotein Ibα drives receptor signaling and platelet clearance
During infection neuraminidase desialylates platelets and induces their rapid clearance from
circulation. The underlying molecular basis, particularly the role of platelet glycoprotein (GP) …
circulation. The underlying molecular basis, particularly the role of platelet glycoprotein (GP) …
Nucleic acid therapeutics: a focus on the development of aptamers
Introduction Aptamers provide exciting opportunities for the development of specific and
targeted therapeutic approaches. Areas covered In this review, the authors discuss different …
targeted therapeutic approaches. Areas covered In this review, the authors discuss different …
Frozen and cold-stored platelets: reconsidered platelet products
T Jimenez-Marco, A Castrillo, F Hierro-Riu, V Vicente… - Platelets, 2022 - Taylor & Francis
Platelet transfusion, both prophylactic and therapeutic, is a key element in modern medicine.
Currently, the standard platelet product for clinical use is platelet concentrates at room …
Currently, the standard platelet product for clinical use is platelet concentrates at room …
Recent insights into the regulation of coagulation and thrombosis
X Li, MMS Sim, JP Wood - Arteriosclerosis, thrombosis, and …, 2020 - Am Heart Assoc
Although procoagulant TF is clearly expressed in the vascular subendothelium, it has also
been proposed that many different cell types express an inactive, encrypted form of TF that …
been proposed that many different cell types express an inactive, encrypted form of TF that …
Serum assisted PD-L1 aptamer screening for improving its stability
Y Zhou, H Zhang, Y Ding, C Yu, H Li - Scientific Reports, 2025 - nature.com
Aptamers have shown potential for diagnosing clinical markers and targeted treatment of
diseases. However, their limited stability and short half-life hinder their broader applications …
diseases. However, their limited stability and short half-life hinder their broader applications …
Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold-stored platelets
S Hegde, H Akbar, AM Wellendorf, S Nestheide… - Blood, 2024 - ashpublications.org
Patients with thrombocytopenia require platelet transfusion to prevent and stop hemorrhage.
Cold storage of platelets results in complex molecular lesions, including changes in …
Cold storage of platelets results in complex molecular lesions, including changes in …
Targeting biophysical cues to address platelet storage lesions
S Wang, Q Liu, L Cheng, L Wang, F Xu, C Yao - Acta Biomaterialia, 2022 - Elsevier
Platelets play vital roles in vascular repair, especially in primary hemostasis, and have been
widely used in transfusion to prevent bleeding or manage active bleeding. Recently …
widely used in transfusion to prevent bleeding or manage active bleeding. Recently …